Strategies to Inhibit Cyst Formation in ADPKD
Open Access
- 1 July 2008
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 3 (4) , 1205-1211
Abstract
The many hundreds of cysts that grow and expand and ultimately overwhelm and destroy polycystic kidneys arise from the slow but unrelenting proliferation of tubular epithelial cells, eventually giving rise to very large, thin-walled, fluid-filled structures. The growth of these cystic bodies requires two processes: Cell proliferation and fluid secretion. Cyst epithelial cells seem to have a unique phenotype that could offer opportunities for therapeutic intervention. Current evidence has demonstrated that cAMP drives both abnormal cell proliferation, by stimulating the Ras/mitogen-activated protein kinase (MAPK) pathway, and cyst-filling fluid secretion, by activating the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. Both of these cAMP-mediated processes should be considered in the design of strategies targeted to slow cyst growth and enlargement in autosomal dominant polycystic kidney disease.Keywords
This publication has 55 references indexed in Scilit:
- Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal ciliaHuman Molecular Genetics, 2008
- Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1Human Molecular Genetics, 2008
- Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2008
- A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1Nature Medicine, 2007
- Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling systemKidney International, 2007
- Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney diseaseProceedings of the National Academy of Sciences, 2007
- Cell biology of polycystin-2Cellular Signalling, 2007
- The Pathogenesis of Autosomal Dominant Polycystic Kidney DiseaseNephron Experimental Nephrology, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD ratsKidney International, 2003